Spirair Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $24.7M

  • Investors
  • 6

Spirair General Information

Description

Developer of minimally invasive medical devices designed to treat nasal septal deviation. The company's device transforms the nasal obstruction treatment procedure from surgery to an in-office procedure, providing doctors with strong outcomes and a better patient experience.

Contact Information

Website
www.spirair.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 415 Grand Avenue
  • Suite 201
  • South San Francisco, CA 94080
  • United States
+1 (844)
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • 415 Grand Avenue
  • Suite 201
  • South San Francisco, CA 94080
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spirair Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 10-Mar-2026 $24.7M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Aug-2021 Completed Generating Revenue
To view Spirair’s complete valuation and funding history, request access »

Spirair Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A-2 1,887,264 $0.000010 $1.1 $1.1 1x $1.1 4.12%
Series A-1 6,290,343 $0.000010 $1.41 $1.41 1x $1.41 13.75%
To view Spirair’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Spirair Patents

Spirair Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260137406-A1 Minimally invasive nasal turbinate surgery Pending 18-Nov-2024
WO-2026107520-A1 Minimally invasive nasal turbinate surgery Pending 18-Nov-2024
US-20260137477-A1 Minimally invasive shaping of nasal tissues Pending 18-Nov-2024
WO-2026107517-A1 Minimally invasive shaping of nasal tissues Pending 18-Nov-2024
AU-2023391051-A1 Devices, systems, and methods for manipulating nasal tissues Pending 09-Dec-2022 A61F5/08
To view Spirair’s complete patent history, request access »

Spirair Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spirair Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
1809 Capital Venture Capital Minority
Cadence Healthcare Ventures Venture Capital Minority
Led By Reason Venture Capital Minority
MedVenture Partners (Japan) Venture Capital Minority
Sonder Capital Management Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Spirair FAQs

  • When was Spirair founded?

    Spirair was founded in 2020.

  • Where is Spirair headquartered?

    Spirair is headquartered in South San Francisco, CA.

  • What is the size of Spirair?

    Spirair has 24 total employees.

  • What industry is Spirair in?

    Spirair’s primary industry is Surgical Devices.

  • Is Spirair a private or public company?

    Spirair is a Private company.

  • What is the current valuation of Spirair?

    The current valuation of Spirair is .

  • What is Spirair’s current revenue?

    The current revenue for Spirair is .

  • How much funding has Spirair raised over time?

    Spirair has raised $34.7M.

  • Who are Spirair’s investors?

    1809 Capital, Cadence Healthcare Ventures, Led By Reason, MedVenture Partners (Japan), and Sonder Capital Management are 5 of 6 investors who have invested in Spirair.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process